Diantha Duvall
SecretaryMs. Diantha Duvall, C.P.A., M.B.A., serves as Director at BioTheryX, Inc. since August 2021. She serves as Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer at Curis, Inc. since August 5, 2022 and served as its Assistant Secretary, Treasurer & Secretary since August 5, 2022, joined the Curis Inc. on July 26, 2022 as senior vice president of strategy. She served as Chief Financial Officer of Genocea Biosciences, Inc. from March 5, 2019 until June 2022 and serves as its Secretary. She served as Chief Accounting Officer and Vice President of Controller at Bioverativ Inc. since February 1, 2017 until January 2019. Ms. Duvall served as Global Commercial Controller for Biogen since January 2016 until January 2017 and U.S. Commercial Controller since February 2015. She served as Executive Director at Merck and Co. In addition, she gained extensive experience in SEC reporting, Sarbanes Oxley compliance, transaction support and risk management while at PricewaterhouseCoopers from 1996 to 2019. Ms. Duvall has a Master of Science in Accounting and Master of Business Administration from Northeastern University and a Bachelor of Arts from Colby College.
Positions
- Company NameGenocea Biosciences, Inc.Stock CodeGNCAQPositionSecretary
- Company NameCuris, Inc.Stock CodeCRISPositionCFO and Principal Financial & Accounting OfficerColleagues
- JEJames E. DentzerPresident, CEO, Secretary, Treasurer & Director
- MDMartyn D. GreenacreIndependent Chairman of the Board
- DDDiantha DuvallCFO and Principal Financial & Accounting Officer
- JBJonathan B. ZungChief Development Officer
- MWMark W. NoelVice President of Technology Management & Intellectual Property
- RBRachel BlasbalgSenior Director of Human Resources
- KIKenneth I. KaitinIndependent Director
- MRMarc RubinIndependent Director
- JAJohn A. HohnekerIndependent Director
